Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 102 (Search time: 0.003 seconds).

previous
1
2
3
4
5
...
11
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2019	OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL	Evans, K.; Duan, J.X.; Pritchard, T.; Jones, C.D.; McDermott, L.; Gu, Z.; Toscan, C.E.; El-Zein, N.; Mayoh, C.; Erickson, S.W.; Guo, Y.; Meng, F.; Jung, D.; Rathi, K.S.; Roberts, K.G.; Mullighan, C.G.; Shia, C.S.; Pearce, T.; Teicher, B.A.; Smith, M.A.; et al.
	2017	Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer	Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
	2020	The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1	Carmichael, C.L.; Wang, J.; Nguyen, T.; Kolawole, O.; Benyoucef, A.; De Mazière, C.; Milne, A.R.; Samuel, S.; Gillinder, K.; Hediyeh-Zadeh, S.; Vo, A.N.Q.; Huang, Y.; Knezevic, K.; McInnes, W.R.L.; Shields, B.J.; Mitchell, H.; Ritchie, M.E.; Lammens, T.; Lintermans, B.; Van Vlierberghe, P.; et al.
	2019	Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma	Neubauer, H.A.; Tea, M.N.; Zebol, J.R.; Gliddon, B.L.; Stefanidis, C.; Moretti, P.A.B.; Pitman, M.R.; Costabile, M.; Kular, J.; Stringer, B.W.; Day, B.W.; Samuel, M.S.; Bonder, C.S.; Powell, J.A.; Pitson, S.M.
	2020	Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion	Kohno, S.; Linn, P.; Nagatani, N.; Watanabe, Y.; Kumar, S.; Soga, T.; Takahashi, C.
	2020	Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration	Po uha, S.T.; Le Grand, M.; Brandl, M.B.; Gifford, A.J.; Goodall, G.J.; Khew-Goodall, Y.; Kavallaris, M.
	2011	Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8⁺CD4⁺ T cells: evidence from myeloma-bearing mouse model	Freeman, L.; Lam, A.; Petcu, E.; Smith, R.; Salajegheh, A.; Diamond, P.; Zannettino, A.; Evdokiou, A.; Luff, J.; Wong, P.; Khalil, D.; Waterhouse, N.; Vari, F.; Rice, A.; Catley, L.; Hart, D.; Vuckovic, S.
	2019	Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer	Watt, M.J.; Clark, A.K.; Selth, L.A.; Haynes, V.R.; Lister, N.; Rebello, R.; Porter, L.H.; Niranjan, B.; Whitby, S.T.; Lo, J.; Huang, C.; Schittenhelm, R.B.; Anderson, K.E.; Furic, L.; Wijayaratne, P.R.; Matzaris, M.; Montgomery, M.K.; Papargiris, M.; Norden, S.; Febbraio, M.; et al.
	2015	Colloidally stabilized magnetic carbon nanotubes providing MRI contrast in mouse liver tumors	Liu, Y.; Muir, B.W.; Waddington, L.J.; Hinton, T.M.; Moffat, B.A.; Hao, X.; Qiu, J.; Hughes, T.C.
	2017	Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer	Paltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.